Important: The following data is for information purposes only. Please note that access to VAC drug benefits will vary depending upon an individual's eligibility and specific health needs. More Details
This information was posted August 29, 2012. Additions or revisions to the Formulary may have subsequently occurred.
Displaying 13051 - 13060 of 24215
Identification Number | Trade Name | Benefit Category |
---|---|---|
02310295 | MYLAN-VENLAFAXINE XR CAP 150MG | Standard Benefit for Eligible Clients |
02310317 | SANDOZ VENLAFAXINE XR CAP 37.5MG | Standard Benefit for Eligible Clients |
02310325 | SANDOZ VENLAFAXINE XR CAP 75MG | Standard Benefit for Eligible Clients |
02310333 | SANDOZ VENLAFAXINE XR CAP 150MG | Standard Benefit for Eligible Clients |
02310341 | SANDOZ OLANZAPINE TAB 2.5MG | Standard Benefit for Eligible Clients |
02310368 | SANDOZ OLANZAPINE TAB 5MG | Standard Benefit for Eligible Clients |
02310376 | SANDOZ OLANZAPINE TAB 7.5MG | Standard Benefit for Eligible Clients |
02310384 | SANDOZ OLANZAPINE TAB 10MG | Standard Benefit for Eligible Clients |
02310392 | SANDOZ OLANZAPINE TAB 15MG | Standard Benefit for Eligible Clients |
02310406 | SANDOZ OLANZAPINE TAB 20MG | Standard Benefit for Eligible Clients |
Displaying 13051 - 13060 of 24215